MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate Tissue
Clinical trial NCT02680535 · COMPLETED
Trial details
- NCT number
- NCT02680535
- Sponsor
- Nanospectra Biosciences, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2020-10-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.